Literature DB >> 2537785

A standard for low molecular weight heparin?

H C Hemker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2537785     DOI： 10.1159/000215881

Source DB:  PubMed          Journal:  Haemostasis        ISSN： 0301-0147


× No keyword cloud information.
  5 in total

1.  Low-dose and heparin-free hemodialysis in children.

Authors:  D F Geary; M Gajaria; S Fryer-Keene; J Willumsen
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

Review 2.  Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.

Authors:  R Davis; D Faulds
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 3.  Nadroparin calcium. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders.

Authors:  L B Barradell; M M Buckley
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 4.  Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders.

Authors:  J E Frampton; D Faulds
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 5.  Prophylaxis of venous thromboembolism in brain tumor patients.

Authors:  M G Hamilton; R D Hull; G F Pineo
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.